Medicare Part D Formulary Changes to Check Now

Your Medicare Part D plan can change its formulary, the list of covered drugs, every calendar year. Those changes can quietly raise your monthly costs, add prior authorization hurdles, or drop a medication you rely on. If you do not review the formulary before the next plan year begins, you may face surprise bills at the pharmacy counter or a scramble to find a new plan during a narrow window. This guide explains exactly what to check, how to look up your drugs, and when a formulary change should prompt a plan switch.

What a Formulary Is and Why Tiers Drive Your Costs

A formulary is the list of prescription drugs a Part D plan covers. Each drug on the list is assigned to a tier, and the tier determines your share of the cost. Plans typically use five tiers, ranging from generic drugs on the lowest tier to specialty medications on the highest. The same drug can sit on different tiers across different plans, so a tier change from one year to the next can shift your copay dramatically. For example, a drug that was Tier 2 with a $10 copay might move to Tier 4 with a 40 percent coinsurance requirement, turning a predictable monthly expense into a variable one that can run into the hundreds.

Tiers matter because Part D plans negotiate rebates and discounts with drug manufacturers and pharmacies. When those negotiations change, the plan may move a drug to a higher tier, add utilization management rules, or remove it from the formulary entirely. Consumers should check the formulary annually, usually in the fall when plans release next year's documents. The Annual Notice of Change (ANOC) mailed each September summarizes the changes, but the full formulary is the authoritative source. Reading only the ANOC can leave gaps, especially if you take several medications or use a preferred pharmacy that is also changing.

Formulary changes also interact with the Part D deductible and the coverage gap. A higher tier drug may not count toward the deductible the same way, or it may be excluded from the standard cost-sharing structure until you reach a certain spending threshold. Consumers should check three things for each medication: whether it is still on the formulary, what tier it occupies, and whether any utilization management rules apply. That triple check is the foundation of every Part D formulary review, and it is the specific set of Medicare Part D formulary changes consumers should check first.

How to Look Up Your Medications in a Plan's Formulary

Every Part D plan publishes its formulary online, usually as a searchable PDF or a web tool on the plan's website. Start by gathering your medication list, including the exact strength and dosage form, because a plan may cover the tablet but not the capsule or the extended-release version. Then use the plan's formulary search tool to look up each drug. The result will show the tier, any prior authorization or step therapy requirement, and whether the drug is subject to quantity limits. If the drug is not listed, it is generally not covered, though the plan may have an exception process.

For a structured review, follow this sequence:

1. List every prescription you take, including the name, strength, and frequency.
2. Open the plan's formulary search tool and check each drug for tier and restrictions.
3. Note any drug that moved to a higher tier, added prior authorization, or disappeared.
4. Compare the total annual cost under the new formulary against your current spending.
5. Repeat the process for at least two alternative plans before deciding whether to switch.

After completing the lookup, calculate your estimated annual out-of-pocket cost for each plan, not just the monthly premium. A plan with a low premium but a high tier for your main drug can cost far more over a year than a plan with a slightly higher premium and better formulary placement. This calculation is where most consumers discover that a formulary change justifies switching plans. Agents who use lead platforms to find new clients often walk prospects through this exact exercise, and tools like those from HomeRemodelingLeads show how a well-organized lead marketplace can streamline client intake, though for Medicare the equivalent is a structured formulary review during every enrollment conversation.

Handling Prior Authorization and Step Therapy Requirements

Prior authorization and step therapy are utilization management tools that plans use to control costs. Prior authorization means the plan must approve a drug before it will cover it, often requiring your prescriber to submit clinical documentation. Step therapy requires you to try a lower-cost alternative before the plan will cover the more expensive drug. When a formulary change adds either requirement to a medication you already take, you may face delays at the pharmacy or a denial that requires an appeal. Consumers should check for these flags on the formulary and ask their prescriber whether documentation can be submitted in advance.

If a drug you take is newly subject to prior authorization, the plan must generally allow a transition fill or a temporary supply during the first 90 days of the plan year for continuing patients. That transition period gives you and your prescriber time to request an exception or switch to a covered alternative. However, transition fills are not automatic in every situation, and they do not apply to new prescriptions. Consumers should confirm the transition policy with the plan and request a written explanation of the exception process. If the plan denies coverage, you have the right to appeal, and the appeal must be decided within a set timeframe depending on whether it is a standard or expedited request.

Step therapy changes can be especially disruptive because they may require you to fail on a different drug before the plan covers yours. If your prescriber believes the step therapy requirement is inappropriate for your clinical situation, they can request an exception. Consumers should keep records of every communication with the plan and pharmacy, including dates, names, and reference numbers. Those records are essential if an appeal becomes necessary. Agents who work with Medicare leads should build a routine that includes checking utilization management flags for every client's drug list during the Annual Enrollment Period, because a missed flag can turn into a January customer service crisis.

When a Formulary Change Justifies Switching Plans

A formulary change does not always mean you should switch plans. Sometimes the increase is modest and the plan's other features, such as pharmacy network or premium, still make it the best choice. But certain changes are strong signals that it is time to compare alternatives. If a drug you take daily moves to a specialty tier with coinsurance above 30 percent, if a drug is removed from the formulary with no covered alternative, or if prior authorization is added to a medication you have taken for years, switching deserves serious consideration. The decision should be based on total annual cost, not just the premium or the copay at a single pharmacy visit.

Consider a concrete example. A consumer takes two brand-name drugs and one generic. In the current year, the brands are Tier 3 with a $47 copay each, and the generic is Tier 1 with a $0 copay. The next year's formulary moves one brand to Tier 4 with 33 percent coinsurance, which at a retail price of $400 per month means about $132 per month, or roughly $1,000 more per year. The other brand stays on Tier 3. If an alternative plan keeps both brands on Tier 3 for a premium that is $20 more per month, the alternative plan saves about $760 per year. This is the kind of arithmetic consumers should run before deciding to stay put. A simple spreadsheet with columns for premium, deductible, tier costs, and utilization management flags makes the comparison manageable.

Consumers should also check whether the plan's pharmacy network changed. A formulary may list a drug as covered, but if the only preferred pharmacy in your area dropped out of the network, your cost could rise even if the tier stayed the same. Preferred pharmacy status and mail-order requirements are part of the same review. If you rely on a local pharmacy for convenience or language access, confirm that it remains in-network for the next plan year. The combination of formulary, tier, utilization management, and pharmacy network changes is what makes the annual review worthwhile.

Coordinating Part D Reviews With Your Annual Enrollment Period Checkup

The Annual Enrollment Period (AEP) runs from October 15 to December 7 each year, and it is the main window for switching Part D plans. Formulary documents for the next plan year are typically available by early October, which gives consumers a few weeks to review changes before AEP begins. The most efficient approach is to schedule a Part D review as part of a broader annual Medicare checkup. During that checkup, review your current plan's formulary changes, compare at least two alternatives, and confirm that your pharmacy remains in-network. If you take multiple medications or have a chronic condition, start the review as soon as the next year's formulary is posted.

Agents and agencies can make this process easier for clients by using a standardized intake form that captures the full medication list, preferred pharmacy, and any utilization management history. Many agencies use lead generation services to find consumers who are actively reviewing their coverage, and platforms such as MedicareLeads.com offer exclusive leads, shared leads, inbound calls, and live transfers that connect agents with consumers during the enrollment window. For consumers who prefer to work independently, the plan's own formulary search tool and the Medicare Plan Finder are the primary resources. For more detail on how coverage interacts across parts of Medicare, see our guide on Medicare Part A coverage for surgeon fees, which explains how hospital and surgical costs fit into the broader picture.

Timing matters because a formulary change discovered in January is much harder to fix than one discovered in October. If you miss AEP, you may be able to switch plans during the Medicare Advantage Open Enrollment Period from January 1 to March 31, but that window applies only to people already enrolled in a Medicare Advantage plan and does not apply to stand-alone Part D plans. Outside those windows, a Special Enrollment Period may apply if you qualify, for example due to a move or a change in extra help status. Consumers should not assume they can switch at any time. The safe approach is to review formulary changes every fall, before AEP closes, and to document the comparison so the decision is defensible if costs rise later.

Finally, keep in mind that formulary changes can happen mid-year in limited circumstances, such as when a drug is removed from the market or a safety warning is issued. Plans must notify affected enrollees in writing, and they must generally provide access to a transition supply or a similar drug. Consumers who receive a mid-year formulary change notice should contact the plan immediately to understand their options. The annual review is still the most important habit, but mid-year notices deserve prompt attention.

Reviewing Medicare Part D formulary changes consumers should check is one of the highest-value habits a beneficiary can build. It takes an hour or two each fall, prevents surprise pharmacy bills, and often saves hundreds of dollars per year. Start with your medication list, check the tier and utilization management flags for each drug, compare total annual costs across at least two plans, and confirm your pharmacy is still in-network. If the numbers favor a switch, act before December 7. If you need help working through the comparison, call (510)-663-7016 to speak with a licensed agent who can walk you through the formulary review step by step.